← All organizations

Fovea Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Fovea | Fovea Pharmaceuticals SA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 1, 2016

Acquired by Sanofi-Aventis on Oct 1, 2009

Timeline

2000s

Jan 1, 2005
Fovea Pharmaceuticals— Founded
Oct 1, 2009
Sanofi-Aventis— Acquired By

Drugs by trial phase (6 distinct, 6 trials)

Phase 4 (1 own, 0 via acquisition)

amphotericin b

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

ecallantide

Indications

Studied for

Recent trials (8)

NCT02966301CollaboratorPhase 2Dec 1, 2016
NCT01319487Lead sponsorPhase 2May 1, 2011
NCT01120132Study chairPhase 2May 1, 2010
NCT01120132Lead sponsorPhase 2May 1, 2010
NCT00969293Lead sponsorPhase 1Sep 1, 2009
NCT00833495Lead sponsorPhase 2Jan 1, 2009
NCT00833495Study directorPhase 2Jan 1, 2009
NCT00697944Lead sponsorPhase 4Mar 1, 2008

Details

Founded: Paris, FR Jan 1, 2005
Last known activity: Dec 1, 2016